Cannabix Technologies Inc. (CSE:BLO)
Canada · Delayed Price · Currency is CAD 0.6000
+0.0200 (3.45%)
Jun 12, 2026, 3:59 PM EST
Cannabix Technologies Market Cap
Cannabix Technologies has a market cap or net worth of CAD 73.71 million as of June 12, 2026. Its market cap has increased by 4.71% in one year.
Market Cap
73.71M
Enterprise Value
72.50M
Revenue
158.51K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since December 18, 2013, Cannabix Technologies's market cap has increased from 574.76K to 73.71M, an increase of 12,723.64%. That is a compound annual growth rate of 47.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 73.71M | 4.96% |
| Dec 31, 2025 | 70.22M | 90.58% |
| Dec 31, 2024 | 36.85M | 79.34% |
| Dec 29, 2023 | 20.55M | -44.62% |
| Dec 30, 2022 | 37.10M | -39.81% |
| Dec 31, 2021 | 61.64M | -34.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 338.67M |
| Vector Science and Therapeutics | 282.00M |
| Theralase Technologies | 69.48M |
| Perimeter Medical Imaging AI | 44.50M |
| Cheelcare | 32.05M |
| Conavi Medical | 24.84M |
| Ventripoint Diagnostics | 22.92M |
| Aurora Spine | 17.96M |